Get started
Author

Shailen R. Shah

Observed names: S SHAH, S Shah, S. Shah, S.R. Shah, Shailen Shah
OpenAlex ID: A5004021568
A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.
2013 · D Price, S Shah, et al. · PubMed · 86
Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis
2006 · William Berger, Frank Hampel, et al. · Annals of Allergy Asthma & Immunology · 77
Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis
2004 · Parthiv J. Mahadevia, Shailen Shah, et al. · Annals of Allergy Asthma & Immunology · 62
Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis
2014 · William E. Berger, Shailen Shah, et al. · The Journal of Allergy and Clinical Immunology In Practice · 60
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients
2008 · William W. Busse, Shailen R. Shah, et al. · Journal of Allergy and Clinical Immunology · 50
PDF
Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergie rhinitis: A phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults
2009 · Shailen R. Shah, Anjuli Nayak, et al. · Clinical Therapeutics · 48
Latex allergy and latex sensitization in children and adolescents with meningomyelocele☆☆☆★★★
1998 · Shailen Shah, Michael Cawley, et al. · Journal of Allergy and Clinical Immunology · 36
PDF
Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal spray
2003 · Shailen R. Shah, Christopher Miller, et al. · Clinical Therapeutics · 33
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis
2009 · Shailen Shah, William Berger, et al. · Allergy and Asthma Proceedings · 29
PDF
Willingness to Pay for Sensory Attributes of Intranasal Corticosteroids Among Patients With Allergic Rhinitis
2006 · Parthiv Mahadevia, Shailen Shah, et al. · Journal of Managed Care Pharmacy · 27
PDF
The Efficacy and Tolerability of Inhaled Montelukast Plus Inhaled Mometasone Compared with Mometasone Alone in Patients with Chronic Asthma
2011 · George Philip, César Villarán, et al. · Journal of Asthma · 13
Long-term efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol
2014 · Steven F. Weinstein, Charles P. Andrews, et al. · Allergy and Asthma Proceedings · 11
Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis
2006 · Nancy C. Santanello, Carla DeMuro-Mercon, et al. · Allergy and Asthma Proceedings · 11
Efficacy and Tolerability of Fixed-Dose (FD) and Adjustable-Dose (AD) Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) and FD Fluticasone Propionate/Salmeterol Dry Powder Inhaler (FP/SAL DPI) Within Racial Groups
2009 · S.R. Shah, W.W. Busse, et al. · Journal of Allergy and Clinical Immunology · 5
Rare case of multifocal extradural and intramedullary neurosarcoidosis without pulmonary involvement: a case report and literature review
2021 · Ryan Shields, Olivia Sagan, et al. · Spinal Cord Series and Cases · 4
PDF
Long-term Safety Study of MP29-02 (Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate) in Subjects with Chronic Allergic or Non-allergic Rhinitis
2012 · W.E. Berger, S. Shah, et al. · Journal of Allergy and Clinical Immunology · 2
PDF
Patients with allergic rhinitis prefer budesonide aqueous nasal spray to fluticasone propionate nasal spray based on sensory attributes
2002 · S Shah, CJ Miller, et al. · Journal of Allergy and Clinical Immunology · 1
From Experimental to Emerging: the Rapid Growth of Intralymphatic Immunotherapy in United States Allergy Practices
2025 · M. Stoner, B. Everist, et al. · Annals of Allergy Asthma & Immunology
PDF
Cardiac disease
2011 · Shailen Shah, Sharon Rubin · Series in maternal-fetal medicine
MP29-02 in the Treatment of Nasal Symptoms of Seasonal Allergic Rhinitis
2011 · W. Carr, S.R. Shah, et al. · Journal of Allergy and Clinical Immunology
PDF
Quality of Life and Safety of Olopatadine HCl Nasal Spray for the Treatment of Seasonal Allergic Rhinitis in Children
2008 · N AMAR, S SHAH, et al. · Journal of Allergy and Clinical Immunology
PDF
Olopatadine Nasal Spray 0.6% is Superior to Vehicle and Non-Inferior to Azelastine Nasal Spray 0.1% When Dosed Twice-Daily for the Treatment of Seasonal Allergic Rhinitis
2008 · D. Mohar, P. Ratner, et al. · Journal of Allergy and Clinical Immunology
PDF
Patients' willingness to pay for intranasal corticosteroid therapy: The importance of sensory attributes
2005 · S. Shah, P.J. Mahadevia, et al. · Journal of Allergy and Clinical Immunology
Budesonide Aqueous Nasal Spray (BANS) is preferred over Fluticasone Propionate Nasal Spray (FPNS) based on specific sensory attributes
2003 · S.R. Shah, C. Miller, et al. · Journal of Allergy and Clinical Immunology
Works count: 24
Citation count: 555
H-index: 11
I10-index: 13
Year
Topic
Type